Table 1 First International Conference on Translational Medicine (The 13th Frank and Bobbie Fenner Conference), 1–4 November 2010, John Curtin School of Medical Research, ANU, Canberra, Australia

Participant leaders from the USA, Europe, China, Singapore and Australia:

 Warwick Anderson, CEO, NHMRC, Australia

 Juan Carlos Lopez, Chief Editor, Nature Medicine

 Anthony Hayward, Director, Clinical and Translational Program, NIH, USA

 Alan Schechter, Chief, Molecular Medicine, NIDDK, NIH, USA

 Clay Johnston, Director, UCSF Clinical and Translational Science Institute

 Anantha Shekhar, Director, Indiana Translational Institute, USA

 Dame Sally Davies, Director General of Research and Development and Chief Scientific Adviser for the Department of Health and NHS, London, UK

 Alastair Buchan, Head, Medical Sciences Division (Dean of Medicine), University of Oxford, UK

 Stephen Smith, Dean of Medicine and CEO, Imperial College Healthcare and AHSC

 Bill Powderly, Dean of Medicine, CEO, Dublin Academic Medical Centre

 Jun Wang, Executive Director, BGI-China

 Lin He, Director, Bio-X Center, Shanghai Jiao Tong University and Dean, Institutes of Biomedical Sciences, Fudan University, Shanghai, China

 Ranga Krishnan, Dean, Duke-NUS Medical School, Singapore

 Alain van Gool, Director, Translational Medicine Research Centre, Merck Singapore

 Eran Leitersdorf, Dean, Faculty of Medicine, Hebrew University of Jerusalem, Israel

 Sir Gustav Nossal, AC, CBE, FAA, FRS

 Bruce Singh, Acting Dean, University of Melbourne

 Steve Wesselingh, Dean of the Faculty of Medicine, Monash University

 Bruce Robinson, Dean, University of Sydney School of Medicine